this smells of desperation
1. NS2 trials were supposed to start in October
the company promised to keep the market updated on this last quarter which they did not which makes it clear the trials got further delayed (delaying revenue as a result)
2. the second 5 eyes deal was promised to the market to happen early October
nothing of a material nature has been negotiated otherwise it would have been its own price sensitive announcement
adding a few more devices/licenses as they mention in this update is peanuts in terms of revenue
likewise for the defence force customer - if it was material they would have to announce it separately
3. the major of content in this update is the same old regurgitated crap we have been fed throughout 2021,2022,2023 - clearly the CEO is incapable otherwise we would have been CFP 6 months ago as promised to the market on several occasions
the company needs hundreds/thousands of new licences secured to have a strong impact on revenue growth - a few here and there will take them donkeys years to get to cash flow positive
disclaimer I own shares in ASX HTG
do not rely on anything I say
do your own homework & research
Add to My Watchlist
What is My Watchlist?
